The Lps locus: Genetic regulation of host responses to bacterial lipopolysaccharide

Inflammation Research

Volumn 48, Issue 12, 1999, Pages 613-620

  Qureshi, S T ^a,b   Gros, P ^a,b   Malo, D ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; MEMBRANE PROTEIN;

CELL ACTIVATION; GENE LOCUS; HOST RESISTANCE; HUMAN; IMMUNOREACTIVITY; INFECTION RESISTANCE; INHERITANCE; MACROPHAGE ACTIVATION; MOLECULAR CLONING; MULTIGENE FAMILY; NONHUMAN; PHAGOCYTOSIS; REVIEW;

ANIMALS; BACTERIA; HUMANS; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED STRAINS; MONOMERIC GTP-BINDING PROTEINS; RAN GTP-BINDING PROTEIN;

EID: 0033376608     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050511     Document Type: Review

References (82)

1. [1] Raetz CRH, Ulevitch RJ, Wright SD, Sibley CH, Ding A, Nathan C. Gram-negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction. FASEB J 1991; 5: 2652-60.
2. [2] Rietschel ET, Kirikae T, Schade FU, Mamat U, Schmidt G, Loppnow H, et al. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 1994; 8: 217-25.
3. [3] Glauser MP, Heumann D, Baumgartner JD, Cohen J. Pathogenesis and potential strategies for prevention and treatment of septic shock: an update. Clin Infect Dis 1994; 18: S205-16.
4. [4] Wenzel RP. Anti-endotoxin monoclonal antibodies-a second look. New Engl J Med 1992; 326: 1151-3.
5. [5] Ulevitch RJ, Tobias PS. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 1995; 13: 437-57.
6. [6] Tobias P, Soldau K, Ulevitch RJ. Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J Exp Med 1986; 164: 777-93.
7. [7] Tobias PS, Mathison JC, Ulevitch RJ. A family of lipopolysaccharide binding proteins involved in responses to Gram-negative sepsis. J Biol Chem 1988; 263: 13479-81.
8. [8] Schumann RR, Leong SR, Flaggs GW, Gray PW, Wright SD, Mathison JK, et al. Structure and function of lipopolysaccharide binding protein. Science 1990; 249: 1429-33.
9. [9] Wurfel MM, Kunitake ST, Lichenstein HS, Kane JP, Wright SD. Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J Exp Med 1994; 180: 1025-35.
10. [10] Hailman E, Lichenstein HS, Wurfel MM, Miller DS, Johnson DA, Kelley M, et al. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J Exp Med 1994; 179: 269-77.
11. [11] Hailman E, Vasselon T, Kelley M, Busse LA, Hu MC-T, Lichenstein HS, et al. Stimulation of macrophages and neutrophils by complexes of lipopolysaccharide and soluble CD14. J Immunol 1996; 156: 4384-90.
12. [12] Wurfel MM, Hailman E, Wright SD. Soluble CD 14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein. J Exp Med 1995; 181: 1743-54.
13. [13] Ziegler-Heitbrock HWL, Ulevitch RJ. CD14: cell surface receptor and differentiation marker. Immunol Today 1993; 12: 121-5.
14. [14] Lee J-D, Kato K, Tobias PS, Kirkland TN, Ulevitch RJ. Transfection of CD14 into 70Z/3 cells dramatically enhances the sensitivity to complexes of lipopolysaccharide (LPS) and LPS binding protein. J Exp Med 1992; 175: 1697-705.
15. [15] Frey EA, Miller DS, Jahr TG, Sundan A, Bazil V, Espevik T, et al. Soluble CD14 participates in the response of cells to lipopolysaccharide. J Exp Med 1992; 176: 1665-71.
16. [16] Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249: 1431-3.
17. [17] Haziot A, Ferrero E, Kontgen F, Hijiya N, Yamamoto S, Silver J, et al. Resistance to endotoxic shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 1996; 4:407-14.
18. [18] Thiéblemont N, Wright SD. Mice genetically hyporesponsive to lipopolysaccharide exhibit a defect in endocytic uptake of LPS and ceramide. J Exp Med 1997; 185: 2095-100.
19. [19] Thieblemont N, Thieringer R, Wright SD. Innate immune recognition of bacterial lipopolysaccharide: dependence on interactions with membrane lipids and endocytic movement. Immunity 1998; 8: 771-7.
20. [20] Rosenstreich DL. Genetic control of the endotoxin response: C3H/HeJ mice. In: Berry LJ, editor. Handbook of Endotoxin, vol. 3. Elsevier, 1985: 82-122.
21. [21] Heppner G, Weiss DW. High susceptibility of strain A mice to endotoxin and endotoxin-red blood cell mixtures. J Bacteriol 1965; 90: 696-703.
22. [22] Sultzer BM. Genetic control of leukocyte responses to endotoxin. Nature 1968; 219: 1253-4.
23. [23] Sultzer BM. Genetic factors in leukocyte responses to endotoxin: further studies in mice. J Immunol 1969; 103: 32-8.
24. [24] Glode LM, Rosenstreich DL. Genetic control of B cell activation by bacterial lipopolysaccharide is mediated by multiple distinct genes or alleles. J Immunol 1976; 117: 2061-6.
25. [25] Coutinho A, Forni L, Melchers F, Watanabe T. Genetic defect in responsiveness to the B cell mitogen lipopolysaccharide. Eur J Immunol 1977; 7: 325-8.
26. [26] McAdam KWPJ, Ryan JL. C57BL/10/CR mice: nonresponders to activation by the lipid A moiety of bacterial lipopolysaccharide. J Immunol 1978; 120: 249-53.
27. [27] Vogel SN, Hansen CT, Rosenstreich DL. Characterization of a congenitally LPS-resistant athymic mouse strain. J Immunol 1979; 122: 619-22.
28. [28] Coutinho A, Meo T. Genetic basis for unresponsiveness to lipopolysaccharide in C57BL/10Cr mice. Immunogenetics 1978; 7: 17-24.
29. [29] Sultzer BM. Genetic control of host responses to endotoxin. Infect Immun 1972; 5: 107-13.
30. [30] Watson J, Riblet R. Genetic control of responses to bacterial lipopolysaccharides in mice I. evidence for a single gene that influences mitogenic and immunogenic responses to lipopolysaccharides. J Exp Med 1974; 140: 1147-61.
31. [31] Coutinho A, Möller G, Gronowicz E. Genetical control of B-cell responses. IV. inheritance of unresponsiveness to lipopolysaccharides. J Exp Med 1975; 142: 253-258.
32. [32] Skidmore BJ, Chiller JM, Weigle WO, Riblet R, Watson J. Immunologic properties of bacterial lipopolysaccharide (LPS). III. Genetic linkage between the in vitro mitogenic and in vivo adjuvant properties of LPS. J Exp Med 1976; 143: 143-50.
33. [33] Scibienski RJ. Defects in murine responsiveness to bacterial lipopolysaccharide. In: Gershwin ME, Merchant B, editors. Immunologie defects in laboratory animals, vol. 2. New York: Plenum Press 1981:241-58.
34. [34] McGhee JR, Michalek SM, Moore RN, Mergenhagen SE, Rosenstreich DL. Genetic control of in vivo sensitivity to lipopolysaccharide: evidence for codominant inheritance. J Immunol 1979; 122: 2052-8.
35. [35] Mergenhagen SE, Pluznik DN. Defective responses to lipid A in C3H/HeJ mice: approaches to an understanding of lipid A-cell interactions. Rev Infect Dis 1984; 6: 519-23.
36. [36] Vogel SN. The Lps gene. Insights into the genetic and molecular basis of LPS responsiveness and macrophage differentiation. In: Beutler B, editor. Tumor necrosis factors: the molecules and their emerging role in medicine. New York: Raven Press, 1992: 485-513.
37. [37] Coutinho A, Forni L, Watanabe T. Genetic and functional characterization of an antiserum to the lipid A-specific triggering receptor on murine B lymphocytes. Eur J Immunol 1978; 8: 63-7.
38. n gene: in vivo evidence for a dominant negative mutation. J Immunol 1999; 162: 5666-70.
39. [39] Watson J, Riblet R, Taylor BA. The response of recombinant inbred strains of mice to bacterial lipopolysaccharides. J Immunol 1977; 118:2088-93.
40. [40] Watson J, Kelly K, Largen M, Taylor BA. The genetic mapping of a defective LPS response gene in C3H/HeJ mice. J Immunol 1978; 120:422-4.
41. [41] Fultz MJ, Vogel SN. The physical separation of Lps and Ifa loci in BXH recombinant inbred mice. J Immunol 1989; 63: 2785-9.
42. d allele: analysis of chromosome 4 markers surrounding the Lps gene. Infect Immun 1994; 62: 4454-9.
43. [43] Qureshi ST, Larivière L, Sebastiani G, Clermont S, Skamene E, Gros P, et al. A high-resolution map in the chromosomal region surrounding the Lps locus. Genomics 1996; 31: 283-94.
44. [44] Peiffer-Schneider S, Schutte BC, Murray JC, Frees KL, Williamson K, Leysens NJ, et al. Exclusion of Ifa and Ifb as the Lps gene and mapping of three markers near the Lps locus. Mamm Genome 1997; 8: 785-6.
45. [45] Poltorak A, Smirnova I, He XL, Liu MY, Van Huffel C, Birdwell D, et al. Genetic and physical mapping of the Lps locus - identification of Toll-4 receptor as a candidate gene in the critical region. Blood Cells Mol Dis 1998; 24: 340-55.
46. [46] Pilz A, Moseley H, Peters J, Abbott C. Comparative mapping of mouse chromosome 4 and human chromosome 9: Lv, Orm, and Hxb are closely linked on mouse chromosome 4. Mamm Genome 1992; 3: 247-9.
47. [47] Pilz A, Woodward K, Povey S, Abbott C. Comparative mapping of 50 human chromosome 9 loci in the laboratory mouse. Genomics 1995; 25: 139-49.
48. [48] Manthey CL, Vogel SN. Interactions of lipopolysaccharide with macrophages. In: Zwilling BS, Eisenstein TK, editors. Macrophage-pathogen interactions. New York; Marcel Dekker 1994: 63-81.
49. [49] Glode LM, Jacques A, Mergenhagen SE, Rosenstreich DL. Resistance of macrophages from C3H/HeJ mice to the in vitro cylotoxic effects of endotoxin. J Immunol 1977; 119: 162-6.
50. [50] Vogel SN, Marshall ST, Rosenstreich DL. Analysis of the effects of lipopolysaccharide on macrophages: differential phagocytic responses of C3H/HeN and C3H/HeJ macrophages in vitro. Infect Immun 1979; 25: 328-36.
51. [51] Wahl LM, Rosenstreich DL, Glode LM, Sandberg AL, Mergenhagen SE. Defective prostaglandin synthesis by C3H/HeJ mouse macrophages stimulated with endotoxin preparations. Infect Immun 1979; 23: 8-13.
52. [52] Vogel SN, Weinblatt AC, Rosenstreich DL. Inherent macrophage defects in mice. In: Gershwin ME, Merchant B, editors. Immunologic defects in laboratory animals. New York: Plenum Press, 1981:327-57.
53. [53] Vogel SN, Bhat N, Qureshi ST, Malo D. Genetic regulation of endotoxin responsiveness: the Lps gene revisited. In: Brade H, Morrison DC, Opal S, Vogel SN, editors. Endotoxin in health and disease. New York: Marcel Dekker, 1999.
54. [54] Watson J, Riblet R. Genetic control of responses to bacterial lipopolysaccharides in mice II. A gene that influences a membrane component involved in the activation of bone marrow-derived lymphocytes by lipopolysaccharide. J Immunol 1975; 114: 1462-8.
55. [55] Vogel SN, Hilfiker ML, Caulfield MJ. Endotoxin-induced T lymphocyte proliferation. J Immunol 1983; 130: 1774-9.
56. [56] Tough DF, Sun S, Sprent J. T cell stimulation in vivo by lipopolysaccharide. J Exp Med 1997; 185: 2089-94.
57. [57] Ryan JL, McAdam KPWJ. Genetic non-responsiveness of murine fibroblasts to bacterial endotoxin. Nature 1977; 269: 153-5.
58. [58] Medzhitov R, Janeway CA Jr. Innate immunity: the virtues of a nonclonal system of recognition. Cell 1997; 91: 295-8.
59. [59] O'Brien AD, Rosenstreich DL, Scher I, Campbell G, MacDermott RP, Formal SB. Genetic control of susceptibility to Salmonella typhimurium in mice: role of the Lps gene. J Immunol 1980; 124: 20-4.
60. [60] Chedid L, Parant M, Damais C, Parant F, Juy D, Galelli A. Failure of endotoxin to increase nonspecific resistance to infection of lipopolysaccharide low-responder mice. Infect Immun 1976; 13: 722-7.
61. [61] Nakano M, Shinomiya H. The Lps mutational defect in C3H/HeJ mice. In: Morrison DC, Ryan JL, editors. Bacterial endotoxin lipopolysaccharides: molecular biochemistry and cellular biology, vol. 1, Boca Raton: CRC Press, 1992: 311-28.
62. [62] Coutinho A, Forni L, Watanabe T. Genetic and functional characterization of an antiserum to the lipid-A-specific triggering receptor on murine B-cells. Eur J Immunol 1978; 8: 63-7.
63. [63] Lei M-G, Morrison DC. Specific endotoxic lipopolysaccharide-binding proteins on murine splenocytes. I. Detection of lipopolysaccharide-binding sites on splenocytes and splenocyte subpopulations. J Immunol 1988; 141: 996-1005.
64. [64] Lei M-G, Morrison DC. Specific endotoxic lipopolysaccharide-binding proteins on murine splenocytes. II. Membrane localization and binding characteristics. J Immunol 1988; 141: 1006-11.
65. [65] Bright SW, Chen T-Y, Flebbe LM, Lei M-G, Morrison DC. Generation and characterization of hamster-mouse hybridomas secreting monoclonal antibodies with specificity for lipopolysaccharide receptor. J Immunol 1990; 145: 1-7.
66. [66] Chen T-Y, Bright SW, Pace JL, Russell SW, Morrison DC. Induction of macrophage-mediated tumor cytotoxicity by a hamster monoclonal antibody with specificity for lipopolysaccharide receptor. J Immunol 1990; 145: 8-12.
67. [67] Kang AD, Wong PMC, Chen H, Castagna R, Chung S-W, Sultzer BM. Restoration of lipopolysaccharide-mediated B-cell response after expression of a cDNA encoding a GTP-binding protein. Infect Immuni 1996; 64: 4612-7.
68. [68] Jin F-y, Nathan C, Radzioch D, Ding A. Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell 1997; 88: 417-26.
69. [69] Poltorak A, He X, Smirnova I, Liu M-Y, Van Huffel C, Du X, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282: 2085-8.
70. [70] Qureshi ST, Larivière L, Leveque G, Clermont S, Moore KJ, Gros P, Malo D. Endotoxin-tolerance mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med 1999; 189: 615-25.
71. [71] Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, et al. Toll-like receptor 4 (Tlr4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for Tlr4 as the Lps gene product. J Immunol 1999; 162: 3749-52.
72. [72] Medzhitov R, Preston-Hurlburt P, Kopp A, Stadien C, Chen C, Ghosh S, et al. MyD88 is an adaptor protein in the hToll/TL-1 receptor family signaling pathways. Mol Cell 1998; 2: 253-8.
73. [73] Belvin MP, Anderson KV. A conserved signaling pathway: the Drosophila Toll-Dorsal pathway. Annu Rev Cell Dev Biol 1996; 12: 393-416.
74. [74] Lemaitre B, Nicolas E, Michaud L, Reichhart J-M, Hoffman JA. The dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 1996; 86: 973-83.
75. [75] Kappler C, Meister M, Lagueux M, Gateff E, Hoffman JA, Reichhart J-M. Insect immunity. Two 17 bp repeats nesting a κB-related sequence confer inducibility to the diptericin gene and bind a polypeptide in bacteria-challenged Drosophila. EMBO J 1993; 12: 1561-8
76. [76] Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997; 388: 394-7.
77. [77] Rock F, Hardiman G, Timans JC, Kasteiein RA, Bazan JF. A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci USA 1998; 95: 588-93.
78. [78] Hammond-Kosack KE, Jones HDG. Plant disease resistance genes. Annu Rev Physiol Plant Mol Biol 1997; 48: 575-607.
79. [79] Wesche H, Henzel WJ, Shillinglaw W, Li S, Cao Z. MyD88: an adaptor that recruits IRAK, to the IL-1 receptor complex. Immunity 1997; 7: 837-47.
80. [80] Yang R-B, Mark MR, Gray A, Huang A, Xie MH, Zhang M, et al. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 1998; 395: 284-8.
81. [81] Kirschning CJ, Wesche H, Ayres TM, Rothe M. Human Toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J Exp Med 1998; 188:2091-7.
82. [82] Kuhns DB, Long Priel DA, Gallin JI. Endotoxin and IL-1 hyporesponsiveness in a patient with recurrent bacterial infections. J Immunol 1997; 158: 3959-64.